BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
Number Citing Articles
1 Mcmanus D, Davis M, Ortiz A, Britto C, Dela Cruz CS, Topal J. Immunomodulatory agents for COVID-19 pneumonia. Clinics in Chest Medicine 2022. [DOI: 10.1016/j.ccm.2022.11.009] [Reference Citation Analysis]
2 Suryadevara N, Kumar A, Ye X, Rogers M, Williams JV, Wilson JT, Karijolich J, Joyce S. A molecular signature of lung-resident CD8+ T cells elicited by subunit vaccination. Sci Rep 2022;12:19101. [DOI: 10.1038/s41598-022-21620-7] [Reference Citation Analysis]
3 Yang K, Liu J, Gong Y, Li Y, Liu Q. Bioinformatics and systems biology approaches to identify molecular targeting mechanism influenced by COVID-19 on heart failure. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1052850] [Reference Citation Analysis]
4 Wiarda JE, Watkins HR, Gabler NK, Anderson CL, Loving CL. Intestinal location- and age-specific variation of intraepithelial T lymphocytes and mucosal microbiota in pigs. Developmental & Comparative Immunology 2022. [DOI: 10.1016/j.dci.2022.104590] [Reference Citation Analysis]
5 Oguma Y, Kuroda Y, Wakao S, Kushida Y, Dezawa M. Single-cell RNA sequencing reveals different signatures of mesenchymal stromal cell pluripotent-like and multipotent populations. iScience 2022;25:105395. [DOI: 10.1016/j.isci.2022.105395] [Reference Citation Analysis]
6 Xu SW, Ilyas I, Weng JP. Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies. Acta Pharmacol Sin 2022. [PMID: 36253560 DOI: 10.1038/s41401-022-00998-0] [Reference Citation Analysis]
7 Li X, Li W, Liu Z, Kang Y, Zhang X, Xu Z, Gao Y, Qi Y. A comparative study of spike protein of SARS-CoV-2 and its variant Omicron (B.1.1.529) on some immune characteristics. Sci Rep 2022;12:17058. [PMID: 36224298 DOI: 10.1038/s41598-022-21690-7] [Reference Citation Analysis]
8 Schmitt CA, Tchkonia T, Niedernhofer LJ, Robbins PD, Kirkland JL, Lee S. COVID-19 and cellular senescence. Nat Rev Immunol 2022. [PMID: 36198912 DOI: 10.1038/s41577-022-00785-2] [Reference Citation Analysis]
9 Wang Z, Tober-Lau P, Farztdinov V, Lemke O, Schwecke T, Steinbrecher S, Muenzner J, Kriedemann H, Sander LE, Hartl J, Mülleder M, Ralser M, Kurth F. The human host response to monkeypox infection: a proteomic case series study. EMBO Mol Med 2022;:e16643. [PMID: 36169042 DOI: 10.15252/emmm.202216643] [Reference Citation Analysis]
10 Pius-sadowska E, Niedźwiedź A, Kulig P, Baumert B, Sobuś A, Rogińska D, Łuczkowska K, Ulańczyk Z, Wnęk S, Karolak I, Paczkowska E, Kotfis K, Kawa M, Stecewicz I, Zawodny P, Machaliński B. CXCL8, CCL2, and CMV Seropositivity as New Prognostic Factors for a Severe COVID-19 Course. IJMS 2022;23:11338. [DOI: 10.3390/ijms231911338] [Reference Citation Analysis]
11 Ankerhold J, Giese S, Kolb P, Maul-Pavicic A, Voll RE, Göppert N, Ciminski K, Kreutz C, Lother A, Salzer U, Bildl W, Welsink T, Morgenthaler NG, Grawitz AB, Emmerich F, Steinmann D, Huzly D, Schwemmle M, Hengel H, Falcone V. Circulating multimeric immune complexes contribute to immunopathology in COVID-19. Nat Commun 2022;13:5654. [PMID: 36163132 DOI: 10.1038/s41467-022-32867-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Bonaguro L, Schulte-Schrepping J, Ulas T, Aschenbrenner AC, Beyer M, Schultze JL. A guide to systems-level immunomics. Nat Immunol 2022. [PMID: 36138185 DOI: 10.1038/s41590-022-01309-9] [Reference Citation Analysis]
13 Gao T, Zhu L, Liu H, Zhang X, Wang T, Fu Y, Li H, Dong Q, Hu Y, Zhang Z, Jin J, Liu Z, Yang W, Liu Y, Jin Y, Li K, Xiao Y, Liu J, Zhao H, Liu Y, Li P, Song J, Zhang L, Gao Y, Kang S, Chen S, Ma Q, Bian X, Chen W, Liu X, Mao Q, Cao C. Highly pathogenic coronavirus N protein aggravates inflammation by MASP-2-mediated lectin complement pathway overactivation. Sig Transduct Target Ther 2022;7. [DOI: 10.1038/s41392-022-01133-5] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
14 Liao T, Wu H, Liao M, Hu W, Tsai K, Lin C, Lu K. The Perspective of Vitamin D on suPAR-Related AKI in COVID-19. IJMS 2022;23:10725. [DOI: 10.3390/ijms231810725] [Reference Citation Analysis]
15 Wiarda JE, Watkins HR, Gabler NK, Anderson CL, Loving CL. Intestinal location- and age-specific variation of intraepithelial T lymphocytes and mucosal microbiota in pigs.. [DOI: 10.21203/rs.3.rs-2019467/v1] [Reference Citation Analysis]
16 Kudryavtsev IV, Arsentieva NA, Korobova ZR, Isakov DV, Rubinstein AA, Batsunov OK, Khamitova IV, Kuznetsova RN, Savin TV, Akisheva TV, Stanevich OV, Lebedeva AA, Vorobyov EA, Vorobyova SV, Kulikov AN, Sharapova MA, Pevtsov DE, Totolian AA. Heterogenous CD8+ T Cell Maturation and ‘Polarization’ in Acute and Convalescent COVID-19 Patients. Viruses 2022;14:1906. [DOI: 10.3390/v14091906] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Qin R, An C, Chen W. Physical-chemical regulation of membrane receptors dynamics in viral invasion and immune defense. J Mol Biol 2022;:167800. [PMID: 36007627 DOI: 10.1016/j.jmb.2022.167800] [Reference Citation Analysis]
18 Urwyler P, Moser S, Trendelenburg M, Sendi P, Osthoff M. Targeting thromboinflammation in COVID-19 - A narrative review of the potential of C1 inhibitor to prevent disease progression. Mol Immunol 2022;150:99-113. [PMID: 36030710 DOI: 10.1016/j.molimm.2022.08.008] [Reference Citation Analysis]
19 Selickman J, Vrettou CS, Mentzelopoulos SD, Marini JJ. COVID-19-Related ARDS: Key Mechanistic Features and Treatments. J Clin Med 2022;11:4896. [PMID: 36013135 DOI: 10.3390/jcm11164896] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Skendros P, Germanidis G, Mastellos DC, Antoniadou C, Gavriilidis E, Kalopitas G, Samakidou A, Liontos A, Chrysanthopoulou A, Ntinopoulou M, Kogias D, Karanika I, Smyrlis A, Cepaityte D, Fotiadou I, Zioga N, Mitroulis I, Gatselis NK, Papagoras C, Metallidis S, Milionis H, Dalekos GN, Willems L, Persson B, Manivel VA, Nilsson B, Connolly ES, Iacobelli S, Papadopoulos V, Calado RT, Huber-Lang M, Risitano AM, Yancopoulou D, Ritis K, Lambris JD. Complement C3 inhibition in severe COVID-19 using compstatin AMY-101. Sci Adv 2022;8:eabo2341. [PMID: 35977025 DOI: 10.1126/sciadv.abo2341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Burt P, Peine M, Peine C, Borek Z, Serve S, Floßdorf M, Hegazy AN, Höfer T, Löhning M, Thurley K. Dissecting the dynamic transcriptional landscape of early T helper cell differentiation into Th1, Th2, and Th1/2 hybrid cells. Front Immunol 2022;13:928018. [DOI: 10.3389/fimmu.2022.928018] [Reference Citation Analysis]
22 Gao J, He J, Zhang F, Xiao Q, Cai X, Yi X, Zheng S, Zhang Y, Wang D, Zhu G, Wang J, Shen B, Ralser M, Guo T, Zhu Y. Integration of protein context improves protein-based COVID-19 patient stratification. Clin Proteomics 2022;19:31. [PMID: 35953823 DOI: 10.1186/s12014-022-09370-0] [Reference Citation Analysis]
23 De Leeuw E, Van Damme KFA, Declercq J, Bosteels C, Maes B, Tavernier SJ, Detalle L, Smart T, Glatt S, Debeuf N, Deckers J, Lameire S, Vandecasteele SJ, De Neve N, Demedts IK, Govaerts E, Knoop C, Vanhove K, Moutschen M, Terryn W, Depuydt P, Van Braeckel E, Haerynck F, Hendrickx TCJ, Parrein V, Lalla M, Brittain C, Lambrecht BN. Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial. Respir Res 2022;23:202. [PMID: 35945604 DOI: 10.1186/s12931-022-02126-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Flaskamp L, Roubal C, Uddin S, Sotzny F, Kedor C, Bauer S, Scheibenbogen C, Seifert M. Serum of Post-COVID-19 Syndrome Patients with or without ME/CFS Differentially Affects Endothelial Cell Function In Vitro. Cells 2022;11:2376. [DOI: 10.3390/cells11152376] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
25 Wang Z, Tober-lau P, Farztdinov V, Lemke O, Schwecke T, Steinbrecher S, Muenzner J, Kriedemann H, Sander LE, Hartl J, Mülleder M, Ralser M, Kurth F. The human host response to monkeypox infection: a proteomic case series study.. [DOI: 10.1101/2022.07.27.22278027] [Reference Citation Analysis]
26 Chen H, Chen Q. COVID-19 Pandemic: Insights into Interactions between SARS-CoV-2 Infection and MAFLD. Int J Biol Sci 2022;18:4756-67. [PMID: 35874945 DOI: 10.7150/ijbs.72461] [Reference Citation Analysis]
27 Dutta K, Friscic J, Hoffmann MH. Targeting the tissue-complosome for curbing inflammatory disease. Semin Immunol 2022;:101644. [PMID: 35902311 DOI: 10.1016/j.smim.2022.101644] [Reference Citation Analysis]
28 Kolb P, Giese S, Voll RE, Hengel H, Falcone V. Immune complexes as culprits of immunopathology in severe COVID-19. Med Microbiol Immunol. [DOI: 10.1007/s00430-022-00743-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Mannes M, Mastellos DC, Ekdahl KN, Nilsson B, Yancopoulou D, Lambris JD, Huber-Lang M. Complement C3 activation in the ICU: Disease and therapy as Bonnie and Clyde. Semin Immunol 2022;:101640. [PMID: 35853795 DOI: 10.1016/j.smim.2022.101640] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Burinskienė A, Seržantė M. Digitalisation as the Indicator of the Evidence of Sustainability in the European Union. Sustainability 2022;14:8371. [DOI: 10.3390/su14148371] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Lim EHT, van Amstel RBE, de Boer VV, van Vught LA, de Bruin S, Brouwer MC, Vlaar APJ, van de Beek D. Complement activation in COVID-19 and targeted therapeutic options: A scoping review. Blood Reviews 2022. [DOI: 10.1016/j.blre.2022.100995] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Makaremi S, Asgarzadeh A, Kianfar H, Mohammadnia A, Asghariazar V, Safarzadeh E. The role of IL-1 family of cytokines and receptors in pathogenesis of COVID-19. Inflamm Res 2022. [PMID: 35751653 DOI: 10.1007/s00011-022-01596-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Frishberg A, Kooistra E, Nuesch-Germano M, Pecht T, Milman N, Reusch N, Warnat-Herresthal S, Bruse N, Händler K, Theis H, Kraut M, van Rijssen E, van Cranenbroek B, Koenen HJ, Heesakkers H, van den Boogaard M, Zegers M, Pickkers P, Becker M, Aschenbrenner AC, Ulas T, Theis FJ, Shen-Orr SS, Schultze JL, Kox M. Mature neutrophils and a NF-κB-to-IFN transition determine the unifying disease recovery dynamics in COVID-19. Cell Rep Med 2022;3:100652. [PMID: 35675822 DOI: 10.1016/j.xcrm.2022.100652] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Li Q, Wang Y, Sun Q, Knopf J, Herrmann M, Lin L, Jiang J, Shao C, Li P, He X, Hua F, Niu Z, Ma C, Zhu Y, Ippolito G, Piacentini M, Estaquier J, Melino S, Weiss FD, Andreano E, Latz E, Schultze JL, Rappuoli R, Mantovani A, Mak TW, Melino G, Shi Y. Immune response in COVID-19: what is next? Cell Death Differ 2022;29:1107-22. [PMID: 35581387 DOI: 10.1038/s41418-022-01015-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
35 Chiarolla CM, Schulz AR, Meir M, Reu-hofer S, Romero-olmedo AJ, Lohoff M, Rosenwald A, Chang H, Schlegel N, Mei HE, Berberich-siebelt F. Pro-inflammatory innate-like T cells are expanded in the blood and inflamed intestine in Crohn’s Disease.. [DOI: 10.1101/2022.05.12.22274864] [Reference Citation Analysis]
36 Henry BM, Sinkovits G, Szergyuk I, de Oliveira MHS, Lippi G, Benoit JL, Favaloro EJ, Pode-shakked N, Benoit SW, Cooper DS, Müller V, Iványi Z, Gál J, Réti M, Gopcsa L, Reményi P, Szathmáry B, Lakatos B, Szlávik J, Bobek I, Prohászka ZZ, Förhécz Z, Csuka D, Hurler L, Kajdácsi E, Cervenak L, Mező B, Kiszel P, Masszi T, Vályi-nagy I, Prohászka Z. Complement Levels at Admission Reflecting Progression to Severe Acute Kidney Injury (AKI) in Coronavirus Disease 2019 (COVID-19): A Multicenter Prospective Cohort Study. Front Med 2022;9:796109. [DOI: 10.3389/fmed.2022.796109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Stegmann KM, Dickmanns A, Heinen N, Blaurock C, Karrasch T, Breithaupt A, Klopfleisch R, Uhlig N, Eberlein V, Issmail L, Herrmann ST, Schreieck A, Peelen E, Kohlhof H, Sadeghi B, Riek A, Speakman JR, Groß U, Görlich D, Vitt D, Müller T, Grunwald T, Pfaender S, Balkema-Buschmann A, Dobbelstein M. Inhibitors of dihydroorotate dehydrogenase cooperate with Molnupiravir and N4-hydroxycytidine to suppress SARS-CoV-2 replication. iScience 2022;:104293. [PMID: 35492218 DOI: 10.1016/j.isci.2022.104293] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Leonardi AJ, Argyropoulos CP, Hamdy A, Proenca RB. Understanding the Effects of Age and T-Cell Differentiation on COVID-19 Severity: Implicating a Fas/FasL-mediated Feed-Forward Controller of T-Cell Differentiation. Front Immunol 2022;13:853606. [PMID: 35309371 DOI: 10.3389/fimmu.2022.853606] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
39 Lamers MM, Haagmans BL. SARS-CoV-2 pathogenesis. Nat Rev Microbiol 2022. [PMID: 35354968 DOI: 10.1038/s41579-022-00713-0] [Cited by in Crossref: 33] [Cited by in F6Publishing: 42] [Article Influence: 33.0] [Reference Citation Analysis]
40 Maisch B, Dörr R. [2 years COVID-19 pandemic-What have we learned?]. Herz 2022;47:177-93. [PMID: 35312833 DOI: 10.1007/s00059-022-05097-8] [Reference Citation Analysis]